4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MediPharm Labs Corp. (LABS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Barrie, Canada with about 127 employees. Its market capitalization is roughly CAD 32 million. In the fiscal year ended 2025-12-31, LABS reported CAD 45M in revenue and (CAD 8M) in net income.
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CAD 45M | CAD 42M | CAD 33M | CAD 22M | — |
| Gross Profit | CAD 14M | CAD 13M | CAD 6M | (CAD 2M) | — |
| Operating Income (EBIT) | (CAD 8M) | (CAD 11M) | (CAD 18M) | (CAD 29M) | — |
| Net Income | (CAD 8M) | (CAD 11M) | (CAD 13M) | (CAD 30M) | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | CAD 9M | CAD 11M | CAD 11M | CAD 12M | CAD 11M | — |
| Gross Profit | CAD 3M | CAD 4M | CAD 3M | CAD 3M | CAD 5M | — |
| Operating Income (EBIT) | (CAD 1M) | (CAD 2M) | (CAD 2M) | (CAD 4M) | (CAD 0M) | — |
| Net Income | (CAD 1M) | (CAD 2M) | (CAD 2M) | (CAD 4M) | (CAD 0M) | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | CAD 0M | CAD 0M | CAD 0M | CAD 0M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | CAD 0M | CAD 0M | CAD 0M | CAD 0M | CAD 0M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CAD 46M | CAD 54M | CAD 64M | CAD 66M | — |
| Total Liabilities | CAD 10M | CAD 10M | CAD 11M | CAD 10M | — |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LABS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms